წყაროები
ძირითადი სტატიები
Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79.სრული ტექსტი აბსტრაქტი
American Diabetes Association. Standards of care in diabetes - 2025. Diabetes Care. 2025 Jan ;48(suppl 1):S1-352.სრული ტექსტი
Dhatariya KK, Glaser NS, Codner E, et al. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020 May 14;6(1):40. აბსტრაქტი
Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016 Apr;12(4):222-32. აბსტრაქტი
გამოყენებული სტატიები
1. Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79.სრული ტექსტი აბსტრაქტი
2. Mauvais-Jarvis F, Sobngwi E, Porcher R, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes. 2004 Mar;53(3):645-53.სრული ტექსტი აბსტრაქტი
3. Umpierrez GE. Ketosis-prone type 2 diabetes: time to revise the classification of diabetes. Diabetes Care. 2006 Dec;29(12):2755-7.სრული ტექსტი
4. American Diabetes Association. Standards of care in diabetes - 2025. Diabetes Care. 2025 Jan ;48(suppl 1):S1-352.სრული ტექსტი
5. Al-Hindi B, Mohammed MA, Mangantig E, et al. Prevalence of sodium-glucose transporter 2 inhibitor-associated diabetic ketoacidosis in real-world data: a systematic review and meta-analysis. J Am Pharm Assoc (2003). 2024 Jan-Feb;64(1):9-26.e6.სრული ტექსტი აბსტრაქტი
6. Umpierrez GE, Woo W, Hagopian WA, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care. 1999 Sep;22(9):1517-23. აბსტრაქტი
7. Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med. 2006 Mar 7;144(5):350-7. აბსტრაქტი
8. Kitabchi AE, Umpierrez GE, Fisher JN, et al. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab. 2008 May;93(5):1541-52. აბსტრაქტი
9. Dhatariya KK, Glaser NS, Codner E, et al. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020 May 14;6(1):40. აბსტრაქტი
10. Kovacs A, Bunduc S, Veres DS, et al. One third of cases of new-onset diabetic ketosis in adults are associated with ketosis-prone type 2 diabetes-a systematic review and meta-analysis. Diabetes Metab Res Rev. 2024 Mar;40(3):e3743.სრული ტექსტი აბსტრაქტი
11. Benoit SR, Zhang Y, Geiss LS, et al. Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):362-65.სრული ტექსტი აბსტრაქტი
12. Centers for Disease Control and Prevention. Diabetes: national diabetes statistics report. May 2024 [internet publication].სრული ტექსტი
13. Nyenwe EA, Kitabchi AE. The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis and management. Metabolism. 2016 Apr;65(4):507-21. აბსტრაქტი
14. Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016 Apr;12(4):222-32. აბსტრაქტი
15. Vuk A, Baretic M, Osvatic MM, et al. Treatment of diabetic ketoacidosis associated with antipsychotic medication: literature review. J Clin Psychopharmacol. 2017 Oct;37(5):584-9. აბსტრაქტი
16. Byun DJ, Braunstein R, Flynn J, et al. Immune checkpoint inhibitor-associated diabetes: a single-institution experience. Diabetes Care. 2020 Dec;43(12):3106-9.სრული ტექსტი აბსტრაქტი
17. Peters AL, Buschur EO, Buse JB, et al. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015 Sep;38(9):1687-93.სრული ტექსტი აბსტრაქტი
18. Kum-Nji JS, Gosmanov AR, Steinberg H, et al. Hyperglycemic, high anion-gap metabolic acidosis in patients receiving SGLT-2 inhibitors for diabetes management. J Diabetes Complications. 2017 Mar;31(3):611-4 აბსტრაქტი
19. Danne T, Garg S, Peters AL, et al. International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors. Diabetes Care. 2019 Jun;42(6):1147-54.სრული ტექსტი აბსტრაქტი
20. Horii T, Oikawa Y, Atsuda K, et al. On-label use of sodium-glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetes. J Diabetes Investig. 2021 Sep;12(9):1586-93.სრული ტექსტი აბსტრაქტი
21. Douros A, Lix LM, Fralick M, et al. Sodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis : a multicenter cohort study. Ann Intern Med. 2020 Sep 15;173(6):417-25. აბსტრაქტი
22. Hampp C, Swain RS, Horgan C, et al. Use of sodium-glucose cotransporter 2 inhibitors in patients with type 1 diabetes and rates of diabetic ketoacidosis. Diabetes Care. 2020 Jan;43(1):90-7.სრული ტექსტი აბსტრაქტი
23. Peters AL, McGuire DK, Danne T, et al. Diabetic ketoacidosis and related events with sotagliflozin added to insulin in adults with type 1 diabetes: a pooled analysis of the inTandem 1 and 2 studies. Diabetes Care. 2020 Nov;43(11):2713-20.სრული ტექსტი აბსტრაქტი
24. Stentz FB, Umpierrez GE, Cuervo R, et al. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004 Aug;53(8):2079-86.სრული ტექსტი აბსტრაქტი
25. Razavi Nematollahi L, Kitabchi AE, Stentz FB, et al. Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism. 2009 Apr;58(4):443-8. აბსტრაქტი
26. Maldonado M, Hampe CS, Gaur LK, et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab. 2003 Nov;88(11):5090-8. აბსტრაქტი
27. McCoy RG, Galindo RJ, Swarna KS, et al. Sociodemographic, clinical, and treatment-related factors associated with hyperglycemic crises among adults with type 1 or type 2 diabetes in the US from 2014 to 2020. JAMA Netw Open. 2021 Sep 1;4(9):e2123471.სრული ტექსტი აბსტრაქტი
28. Randall L, Begovic J, Hudson M, et al. Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care. 2011 Sep;34(9):1891-6.სრული ტექსტი აბსტრაქტი
29. Price HC, Ismail K, Joint British Diabetes Societies (JBDS) for Inpatient Care. Royal College of Psychiatrists Liaison Faculty & Joint British Diabetes Societies (JBDS): guidelines for the management of diabetes in adults and children with psychiatric disorders in inpatient settings. Diabet Med. 2018 Aug;35(8):997-1004.სრული ტექსტი აბსტრაქტი
30. Lindner LME, Rathmann W, Rosenbauer J. Inequalities in glycaemic control, hypoglycaemia and diabetic ketoacidosis according to socio-economic status and area-level deprivation in Type 1 diabetes mellitus: a systematic review. Diabet Med. 2018 Jan;35(1):12-32. აბსტრაქტი
31. Hamblin PS, Topliss DJ, Chosich N, et al. Deaths associated with diabetic ketoacidosis and hyperosmolar coma. 1973-1988. Med J Aust. 1989 Oct 16;151(8):439, 441-2, 444. აბსტრაქტი
32. Hurtado CR, Lemor A, Vallejo F, et al. Causes and predictors for 30-day re-admissions in adult patients with diabetic ketoacidosis in the United States: a nationwide analysis, 2010-2014. Endocr Pract. 2019 Mar;25(3):242-53. აბსტრაქტი
33. Everett E, Mathioudakis NN. Association of socioeconomic status and DKA readmission in adults with type 1 diabetes: analysis of the US National Readmission Database. BMJ Open Diabetes Res Care. 2019;7(1):e000621.სრული ტექსტი აბსტრაქტი
34. Thomas M, Harjutsalo V, Feodoroff M, et al. The long-term incidence of hospitalization for ketoacidosis in adults with established T1D-a prospective cohort study. J Clin Endocrinol Metab. 2020 Jan 1;105(1):dgz003.სრული ტექსტი აბსტრაქტი
35. Nair S, Yadav D, Pitchumoni CS. Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am J Gastroenterol. 2000 Oct;95(10):2795-800. აბსტრაქტი
36. Kopff B, Mucha S, Wolffenbuttel BH, et al. Diabetic ketoacidosis in a patient with acromegaly. Med Sci Monit. 2001 Jan-Feb;7(1):142-7. აბსტრაქტი
37. Cooppan R, Kozak GP. Hyperthyroidism and diabetes mellitus. An analysis of 70 patients. Arch Intern Med. 1980 Mar;140(3):370-3. აბსტრაქტი
38. Rathish D, Karalliyadda S. Concurrent presentation of thyroid storm and diabetic ketoacidosis: a systematic review of previously reported cases. BMC Endocr Disord. 2019 May 17;19(1):49.სრული ტექსტი აბსტრაქტი
39. Nyenwe EA, Loganathan RS, Blum S, et al. Active use of cocaine: an independent risk factor for recurrent diabetic ketoacidosis in a city hospital. Endocr Pract. 2007 Jan-Feb;13(1):22-9. აბსტრაქტი
40. US Food and Drug Administration. FDA drug safety communication: FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections. December 2015 [internet publication].სრული ტექსტი
41. Colacci M, Fralick J, Odutayo A, et al. Sodium-glucose cotransporter-2 inhibitors and risk of diabetic ketoacidosis among adults with type 2 diabetes: a systematic review and meta-analysis. Can J Diabetes. 2022 Feb;46(1):10-5.e2. აბსტრაქტი
42. Chen MB, Xu RJ, Zheng QH, et al. Efficacy and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: a systematic review and meta-analysis. Medicine (Baltimore). 2020 Aug 14;99(33):e20875.სრული ტექსტი აბსტრაქტი
43. Miyoshi Y, Ogawa O, Oyama Y. Nivolumab, an anti-programmed cell death-1 antibody, induces fulminant type 1 diabetes. Tohoku J Exp Med. 2016 Jun;239(2):155-8.სრული ტექსტი აბსტრაქტი
44. Clotman K, Janssens K, Specenier P, et al. Programmed cell death-1 (PD-1) inhibitor induced type 1 diabetes mellitus: mini-review. J Clin Endocrinol Metab. 2018 Sep 1;103(9):3144-54. აბსტრაქტი
45. Akturk HK, Kahramangil D, Sarwal A, et al. Immune checkpoint inhibitor-induced type 1 diabetes: a systematic review and meta-analysis. Diabet Med. 2019 Sep;36(9):1075-81.სრული ტექსტი აბსტრაქტი
46. Association of British Clinical Diabetologists. JBDS 17 the management of glycaemic control in people with cancer. Jan 2023 [internet publication].სრული ტექსტი
47. Acharya R, Kabadi UM. Case of diabetic ketoacidosis as an initial presentation of Cushing's syndrome. Endocrinol Diabetes Metab Case Rep. 2017 Feb 23;2017:16-0123.სრული ტექსტი აბსტრაქტი
48. Kirwan JP, Aminian A, Kashyap SR, Bet al. Bariatric surgery in obese patients with type 1 diabetes. Diabetes Care. 2016 Jun;39(6):941-8.სრული ტექსტი აბსტრაქტი
49. Parmar C, Appel S, Lee L, et al. Choice of bariatric surgery in patients with obesity and type 1 diabetes mellitus? an up-to-date systematic review. Obes Surg. 2022 Dec;32(12):3992-4006. აბსტრაქტი
50. Runyan JW Jr, Zwaag RV, Joyner MB, et al. The Memphis diabetes continuing care program. Diabetes Care. 1980 Mar-Apr;3(2):382-6. აბსტრაქტი
51. Vanelli M, Chiari G, Ghizzoni L, et al. Effectiveness of a prevention program for diabetes ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care. 1999 Jan;22(1):7-9. აბსტრაქტი
52. Phillip M, Achenbach P, Addala A, et al. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetes Care. 2024 Aug 1;47(8):1276-98.სრული ტექსტი
53. Henry RR, Dandona P, Pettus J, et al. Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting β-hydroxybutyrate levels in a phase IIa pilot study. Diabetes Obes Metab. 2017 Jun;19(6):814-21. აბსტრაქტი
54. Goldenberg RM, Berard LD, Cheng AY, et al. SGLT2 inhibitor-associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis. Clin Ther. 2016 Dec;38(12):2654-64.e1. აბსტრაქტი
55. Goldenberg RM, Gilbert JD, Hramiak IM, et al. Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: the STOP DKA protocol. Diabetes Obes Metab. 2019 Oct;21(10):2192-202. აბსტრაქტი
56. Tamsett Z, James S, Brown F, et al. Modifiable factors to prevent severe hypoglycaemic and diabetic ketoacidosis presentations in people with type 1 diabetes. Diabet Med. 2024 Sep;41(9):e15384.სრული ტექსტი აბსტრაქტი
57. Blonde L, Umpierrez GE, Reddy SS, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: developing a diabetes mellitus comprehensive care plan-2022 Update. Endocr Pract. 2022 Oct;28(10):923-1049.სრული ტექსტი აბსტრაქტი
58. Joseph F, Anderson L, Goenka N, et al. Starvation-induced true diabetic euglycemic ketoacidosis in severe depression. J Gen Intern Med. 2009 Jan;24(1):129-31.სრული ტექსტი აბსტრაქტი
59. Musso G, Gambino R, Cassader M, et al. Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials. BMJ. 2019 Apr 9;365:l1328.სრული ტექსტი აბსტრაქტი
60. Li J, Zhu C, Liang J, et al. Cardiovascular benefits and safety of sotagliflozin in type 2 diabetes mellitus patients with heart failure or cardiovascular risk factors: a bayesian network meta-analysis. Front Pharmacol. 2023 Nov 17;14:1303694.სრული ტექსტი აბსტრაქტი
61. Long B, Willis GC, Lentz S, et al. Diagnosis and management of the critically Ill adult patient with hyperglycemic hyperosmolar state. J Emerg Med. 2021 Oct;61(4):365-75. აბსტრაქტი
62. Stoner GD. Hyperosmolar hyperglycemic state. Am Fam Physician. 2017 Dec 1;96(11):729-36.სრული ტექსტი აბსტრაქტი
63. Kemperman FA, Weber JA, Gorgels J, et al. The influence of ketoacids on plasma creatinine assays in diabetic ketoacidosis. J Intern Med. 2000 Dec;248(6):511-7.სრული ტექსტი აბსტრაქტი
64. Dhatariya K. Blood ketones: measurement, interpretation, limitations, and utility in the management of diabetic ketoacidosis. Rev Diabet Stud. 2016 Winter;13(4):217-25. აბსტრაქტი
65. Lowie BJ, Bond MC. Diabetic ketoacidosis. Emerg Med Clin North Am. 2023 Nov;41(4):677-86.სრული ტექსტი აბსტრაქტი
66. Joint British Diabetes Societies for Inpatient Care. The management of diabetic ketoacidosis in adults. Mar 2023 [internet publication].სრული ტექსტი
67. Mein SA, Schwartzstein RM, Richards JB. Sugar, sodium, and water: a recipe for disaster. Ann Am Thorac Soc. 2020 Aug;17(8):1016-20.სრული ტექსტი
68. Kamel KS, Schreiber M, Carlotti AP, et al. Approach to the treatment of diabetic ketoacidosis. Am J Kidney Dis. 2016 Dec;68(6):967-72. აბსტრაქტი
69. Long B, Lentz S, Koyfman A, et al. Euglycemic diabetic ketoacidosis: etiologies, evaluation, and management. Am J Emerg Med. 2021 Jun;44:157-60. აბსტრაქტი
70. Yadav D, Nair S, Norkus EP, et al. Nonspecific hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities. Am J Gastroenterol. 2000 Nov;95(11):3123-8. აბსტრაქტი
71. Chandra D, Bsavaraju M, Mr R, et al. Serum amylase and lipase estimation in diabetic ketoacidosis. J Assoc Physicians India. 2022 Apr;70(4):11-2. აბსტრაქტი
72. Nance JR, Mammen AL. Diagnostic evaluation of rhabdomyolysis. Muscle Nerve. 2015 Jun;51(6):793-810.სრული ტექსტი აბსტრაქტი
73. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med. 2018;56(12):2015-38. აბსტრაქტი
74. Nyenwe EA, Razavi LN, Kitabchi AE, et al. Acidosis: the prime determinant of depressed sensorium in diabetic ketoacidosis. Diabetes Care. 2010 Aug;33(8):1837-9.სრული ტექსტი აბსტრაქტი
75. Matz R. Hypothermia in diabetic acidosis. Hormones. 1972;3(1):36-41. აბსტრაქტი
76. Calimag APP, Chlebek S, Lerma EV, et al. Diabetic ketoacidosis. Dis Mon. 2023 Mar;69(3):101418. აბსტრაქტი
77. Seheult J, Fitzpatrick G, Boran G. Lactic acidosis: an update. Clin Chem Lab Med. 2017 Mar 1;55(3):322-33.სრული ტექსტი აბსტრაქტი
78. Meyer TW, Hostetter TH. Uremia. N Engl J Med. 2007 Sep 27;357(13):1316-25.
79. Fasanmade OA, Odeniyi IA, Ogbera AO. Diabetic ketoacidosis: diagnosis and management. Afr J Med Med Sci. 2008 Jun;37(2):99-105. აბსტრაქტი
80. Andrade OV, Ihara FO, Troster EJ. Metabolic acidosis in childhood: why, when and how to treat. J Pediatr (Rio J). 2007 May;83(2 Suppl):S11-21. აბსტრაქტი
81. Piva JP, Czepielewskii M, Garcia PC, et al. Current perspectives for treating children with diabetic ketoacidosis. J Pediatr (Rio J). 2007 Nov;83(5 Suppl):S119-27. აბსტრაქტი
82. Catahay JA, Polintan ET, Casimiro M, et al. Balanced electrolyte solutions versus isotonic saline in adult patients with diabetic ketoacidosis: a systematic review and meta-analysis. Heart Lung. 2022 Jul-Aug;54:74-9. აბსტრაქტი
83. Alghamdi NA, Major P, Chaudhuri D, et al. Saline compared to balanced crystalloid in patients with diabetic ketoacidosis: a systematic review and meta-analysis of randomized controlled trials. Crit Care Explor. 2022 Jan;4(1):e0613.სრული ტექსტი აბსტრაქტი
84. Jahangir A, Jahangir A, Siddiqui FS, et al. Normal saline versus low chloride solutions in treatment of diabetic ketoacidosis: a systematic review of clinical trials. Cureus. 2022 Jan;14(1):e21324.სრული ტექსტი აბსტრაქტი
85. Liu Y, Zhang J, Xu X, et al. Comparison of balanced crystalloids versus normal saline in patients with diabetic ketoacidosis: a meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2024 May 21;15:1367916.სრული ტექსტი აბსტრაქტი
86. Maharjan J, Pandit S, Arne Johansson K, et al. Effectiveness of interventions for emergency care of hypoglycaemia and diabetic ketoacidosis: a systematic review. Diabetes Res Clin Pract. 2024 Jan;207:111078.სრული ტექსტი აბსტრაქტი
87. Szabó GV, Szigetváry C, Turan C, et al. Fluid resuscitation with balanced electrolyte solutions results in faster resolution of diabetic ketoacidosis than with 0.9% saline in adults - a systematic review and meta-analysis. Diabetes Metab Res Rev. 2024 Jul;40(5):e3831.სრული ტექსტი აბსტრაქტი
88. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.სრული ტექსტი
89. Soar J, Böttiger BW, Carli P, et al. European Resuscitation Council guidelines 2021: adult advanced life support. Resuscitation. 2021 Apr;161:115-51.სრული ტექსტი აბსტრაქტი
90. Colquhoun MC, Handley AJ, Evans TR. ABC of resuscitation. 5th ed. London: BMJ Publishing Group; 2004.
91. Chrimes N, Higgs A, Hagberg CA, et al. Preventing unrecognised oesophageal intubation: a consensus guideline from the Project for Universal Management of Airways and international airway societies. Anaesthesia. 2022 Dec;77(12):1395-415.სრული ტექსტი აბსტრაქტი
92. Gosmanov AR, Gosmanova EO, Dillard-Cannon E. Management of adult diabetic ketoacidosis. Diabetes Metab Syndr Obes. 2014 Jun 30;7:255-64.სრული ტექსტი აბსტრაქტი
93. Alnuaimi A, Mach T, Reynier P, et al. A systematic review and meta-analysis comparing outcomes between using subcutaneous insulin and continuous insulin infusion in managing adult patients with diabetic ketoacidosis. BMC Endocr Disord. 2024 Aug 1;24(1):133.სრული ტექსტი აბსტრაქტი
94. Ludvigsson J, Samuelsson U. Continuous insulin infusion (CSII) or modern type of multiple daily injections (MDI) in diabetic children and adolescents: a critical review on a controversial issue. Pediatr Endocrinol Rev. 2007 Dec;5(2):666-78. აბსტრაქტი
95. Mukhopadhyay A, Farrell T, Fraser RB, et al. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol. 2007 Nov;197(5):447-56. აბსტრაქტი
96. Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, et al. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev. 2016 Jan 21;(1):CD011281.სრული ტექსტი აბსტრაქტი
97. Korytkowski MT, Muniyappa R, Antinori-Lent K, et al. Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2022 Jul 14;107(8):2101-28.სრული ტექსტი აბსტრაქტი
98. Shand JAD, Morrow P, Braatvedt G. Mortality after discharge from hospital following an episode of diabetic ketoacidosis. Acta Diabetol. 2022 Nov;59(11):1485-92. აბსტრაქტი
99. McCoy RG, Herrin J, Galindo RJ, et al. All-cause mortality after hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011-2020. Diabetes Res Clin Pract. 2023 Mar;197:110263.სრული ტექსტი აბსტრაქტი
100. Mays JA, Jackson KL, Derby TA, et al. An evaluation of recurrent diabetic ketoacidosis, fragmentation of care, and mortality across Chicago, Illinois. Diabetes Care. 2016 Oct;39(10):1671-6.სრული ტექსტი აბსტრაქტი
101. Gibb FW, Teoh WL, Graham J, et al. Risk of death following admission to a UK hospital with diabetic ketoacidosis. Diabetologia. 2016 Oct;59(10):2082-7.სრული ტექსტი აბსტრაქტი
102. Lacy ME, Gilsanz P, Eng CW, et al. Recurrent diabetic ketoacidosis and cognitive function among older adults with type 1 diabetes: findings from the Study of Longevity in Diabetes. BMJ Open Diabetes Res Care. 2020 Jun;8(1):e001173.სრული ტექსტი აბსტრაქტი
103. Dhatariya KK, Nunney I, Higgins K, et al. National survey of the management of diabetic ketoacidosis (DKA) in the UK in 2014. Diabet Med. 2016 Feb;33(2):252-60. აბსტრაქტი
104. Pasquel FJ, Tsegka K, Wang H, et al. Clinical outcomes in patients with isolated or combined diabetic ketoacidosis and hyperosmolar hyperglycemic state: a retrospective, hospital-based cohort study. Diabetes Care. 2020 Feb;43(2):349-57.სრული ტექსტი აბსტრაქტი
105. Hillman K. Fluid resuscitation in diabetic emergencies - a reappraisal. Intensive Care Med. 1987;13(1):4-8. აბსტრაქტი
106. Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med. 1986 Dec;105(6):836-40. აბსტრაქტი
107. Muir AB, Quisling RG, Yang MC, et al. Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care. 2004 Jul;27(7):1541-6.სრული ტექსტი აბსტრაქტი
108. Gallo de Moraes A, Surani S. Effects of diabetic ketoacidosis in the respiratory system. World J Diabetes. 2019 Jan 15;10(1):16-22.სრული ტექსტი აბსტრაქტი
109. Konstantinov NK, Rohrscheib M, Agaba EI, et al. Respiratory failure in diabetic ketoacidosis. World J Diabetes. 2015 Jul 25;6(8):1009-23.სრული ტექსტი აბსტრაქტი
110. Kitabchi AE, Fisher JN. Insulin therapy of diabetic ketoacidosis: physiologic versus pharmacologic doses of insulin and their routes of administration. In: Brownlee M, ed. Handbook of diabetes mellitus. New York, NY: Garland ATPM Press; 1981:95-149.
111. Mazer M, Chen E. Is subcutaneous administration of rapid-acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis? Ann Emerg Med. 2009 Feb;53(2):259-63. აბსტრაქტი
112. Scottish Intercollegiate Guidelines Network (SIGN). Management of diabetes: a national clinical guideline. November 2017 [internet publication].სრული ტექსტი
113. Elliott J, Jacques RM, Kruger J, et al. Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with Type 1 diabetes. Diabet Med. 2014 Jul;31(7):847-53.სრული ტექსტი აბსტრაქტი
114. Albanese-O'Neill A, Wu M, Miller KM, et al. Poor adherence to ketone testing in patients with type 1 diabetes. Diabetes Care. 2017 Apr;40(4):e38-9.სრული ტექსტი
115. Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021 Dec;64(12):2609-52.სრული ტექსტი აბსტრაქტი
116. Riveline JP, Roussel R, Vicaut E, et al. Reduced rate of acute diabetes events with flash glucose monitoring is sustained for 2 years after initiation: extended outcomes from the RELIEF study. Diabetes Technol Ther. 2022 Sep;24(9):611-8. აბსტრაქტი
117. Roussel R, Riveline JP, Vicaut E, et al. Important drop in rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in France: the RELIEF study. Diabetes Care. 2021 Jun;44(6):1368-76.სრული ტექსტი აბსტრაქტი
118. Allcock B, Stewart R, Jackson M. Psychosocial factors associated with repeat diabetic ketoacidosis in people living with type 1 diabetes: a systematic review. Diabet Med. 2022 Jan;39(1):e14663.სრული ტექსტი აბსტრაქტი
ამ მასალის გამოყენება ექვემდებარება ჩვენს განცხადებას